DK1871738T3 - N-alkylcarbonylaminosyreester- og N-alkylcarbonylaminolactonforbindelser og deres anvendelse - Google Patents
N-alkylcarbonylaminosyreester- og N-alkylcarbonylaminolactonforbindelser og deres anvendelseInfo
- Publication number
- DK1871738T3 DK1871738T3 DK06710144T DK06710144T DK1871738T3 DK 1871738 T3 DK1871738 T3 DK 1871738T3 DK 06710144 T DK06710144 T DK 06710144T DK 06710144 T DK06710144 T DK 06710144T DK 1871738 T3 DK1871738 T3 DK 1871738T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkylcarbonylaminolactone
- alkylcarbonylamino
- compounds
- acid ester
- ester
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C233/05—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/08—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/86—Hydrazides; Thio or imino analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Addiction (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Otolaryngology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66716605P | 2005-03-29 | 2005-03-29 | |
US68338405P | 2005-05-20 | 2005-05-20 | |
US70250505P | 2005-07-25 | 2005-07-25 | |
US20372805A | 2005-08-13 | 2005-08-13 | |
US77237406P | 2006-02-09 | 2006-02-09 | |
PCT/GB2006/001093 WO2006103401A2 (en) | 2005-03-29 | 2006-03-23 | N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1871738T3 true DK1871738T3 (da) | 2009-09-21 |
Family
ID=36498694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06710144T DK1871738T3 (da) | 2005-03-29 | 2006-03-23 | N-alkylcarbonylaminosyreester- og N-alkylcarbonylaminolactonforbindelser og deres anvendelse |
Country Status (20)
Country | Link |
---|---|
US (2) | US20110082204A1 (da) |
EP (2) | EP1871738B1 (da) |
JP (2) | JP2008538115A (da) |
KR (1) | KR20070116133A (da) |
CN (1) | CN101184725B (da) |
AU (1) | AU2006228280B2 (da) |
BR (1) | BRPI0609784C1 (da) |
CA (1) | CA2602075C (da) |
CY (1) | CY1109420T1 (da) |
DE (1) | DE602006007831D1 (da) |
DK (1) | DK1871738T3 (da) |
ES (1) | ES2328847T3 (da) |
HK (1) | HK1106761A1 (da) |
IL (1) | IL186297A0 (da) |
MX (1) | MX2007011831A (da) |
PL (1) | PL1871738T3 (da) |
PT (1) | PT1871738E (da) |
SI (1) | SI1871738T1 (da) |
WO (1) | WO2006103401A2 (da) |
ZA (1) | ZA200709252B (da) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2618560T3 (es) * | 2005-03-29 | 2017-06-21 | Axalbion Sa | Éster isopropílico del ácido [((1R,2S,5R)-2-isopropil-5-metil-ciclohexanocarbonil)-amino]-acético y compuestos relacionados y su uso en terapia |
DE102006047164A1 (de) * | 2006-09-29 | 2008-04-03 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninmethylester und einem oder mehreren Hautbefeuchtungsmitteln |
DE102006047162A1 (de) * | 2006-09-29 | 2008-04-03 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit Kombinationen aus (R)-2-[((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-propionsäure methyl ester und einer oder mehreren Lichtschutzfiltersubstanzen |
EP1913976A1 (de) * | 2006-10-18 | 2008-04-23 | Symrise GmbH & Co. KG | N-alpha-(Menthancarbonyl)aminosäureamide und deren Verwendung als physiologische Kühlwirkstoffe |
JP2010509299A (ja) * | 2006-11-08 | 2010-03-25 | ウェイ,エドワード,タク | N−アルキルカルボニル−d−アミノ酸ヒドロキシアルキルエステル化合物およびそれらの使用 |
EP2014333A1 (en) * | 2007-07-12 | 2009-01-14 | Hakiman Shargh Research Company | Use of cooling agents for treatment or prevention of lacrimation or eye burning |
GB2451503B (en) * | 2007-08-01 | 2011-10-12 | Lrc Products | Stimulating gel comprising a cyclic carboxamide coolant |
WO2009081107A1 (en) * | 2007-12-21 | 2009-07-02 | Paget, Hugh, Charles, Edward | P-menthawe-3-carboxylic acid esters to treat airways diseases |
DE102008015424A1 (de) * | 2008-03-20 | 2009-09-24 | Beiersdorf Ag | Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5- methylcyclohexancarboxamid mit Menthoxypropandiol |
DE102008015426A1 (de) * | 2008-03-20 | 2009-09-24 | Beiersdorf Ag | Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid zu Reduktion von Hautrötungen |
MX2011001724A (es) | 2008-08-15 | 2011-03-21 | Procter & Gamble | Sintesis de derivados de ciclohexano utiles como agentes de sensacion en productos de consumo. |
EP2313070A1 (en) | 2008-08-15 | 2011-04-27 | The Procter & Gamble Company | Solution of menthane carboxamides for use in consumer products |
BRPI0920909B1 (pt) | 2008-11-20 | 2017-04-18 | Procter & Gamble | método de acentuação e/ou modulação da atividade de um ou mais agentes refrigerantes não mentol e composições de cuidados pessoais para uso oral |
US20120128754A1 (en) * | 2009-06-05 | 2012-05-24 | Edward Tak Wei | Treatment of eye discomfort by topical administration of a cooling agent to the external surface of the eyelid |
EP2186506B1 (de) | 2009-10-06 | 2015-09-30 | Symrise AG | Mentholhaltige Zahnputz-Zusammensetzung mit reduzierter Bitterwahrnehmung |
US9446267B2 (en) | 2009-10-06 | 2016-09-20 | Symrise Ag | Products comprising a flavoring agent composition |
US20120014883A1 (en) | 2010-07-19 | 2012-01-19 | Douglas Craig Scott | Compositions Comprising Derivatives Of Essential Oil Compounds And Use In Personal Care Products |
CN103140209B (zh) | 2010-10-01 | 2017-10-13 | 宝洁公司 | 具有改善的风味的口腔护理组合物 |
CN103339103B (zh) * | 2010-12-06 | 2015-06-17 | 魏德烽 | [((1r,2s,5r)-2-异丙基-5-甲基-环己烷羰基)-氨基]乙酸异丙酯和相关化合物及它们在治疗中的应用 |
CN103458928B (zh) | 2011-01-18 | 2015-09-30 | 魏德烽 | (r)-1,2-丙二醇用作治疗性冷却剂组合物中的溶剂 |
US8426463B2 (en) * | 2011-04-04 | 2013-04-23 | Edward T. Wei | [((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy |
US20130042482A1 (en) | 2011-08-16 | 2013-02-21 | Valerie Jean Bradford | Skin Engaging Member Comprising An Anti-Irritation Agent |
BR112014004274A2 (pt) | 2011-09-01 | 2017-01-10 | Procter & Gamble | composições para tratamento bucal com reologia aprimorada |
EP2793877B2 (en) * | 2011-12-21 | 2022-05-04 | WM. Wrigley Jr. Company | Chewing gum products containing [(2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester |
US20130315843A1 (en) | 2012-05-25 | 2013-11-28 | The Procter & Gamble Company | Composition for reduction of trpa1 and trpv1 sensations |
MX355922B (es) | 2012-09-28 | 2018-05-03 | Gillette Co Llc | Un miembro de acoplamiento con la piel que comprende al menos un agente percibido por los sentidos térmicamente resilente. |
EP2900332B1 (en) | 2012-09-28 | 2017-08-02 | The Gillette Company LLC | A skin engaging shaving aid member comprising at least one thermally resilient sensate |
US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
JP2016535027A (ja) | 2013-10-22 | 2016-11-10 | エドワード タク ウェイWEI, Edward Tak | 非角化重層上皮(NKSE)組織の不快感の治療用局所薬としての1−ジ(sec−ブチル)−ホスフィノイル−ペンタン(DAPA−2−5) |
EP3060569B8 (en) | 2013-10-22 | 2021-11-24 | IVIEW Therapeutics, Inc. | Di-isopropyl-phosphinoyl-alkane (dapa) compounds as topical agents for the treatment of sensory discomfort |
US9884130B2 (en) | 2013-11-13 | 2018-02-06 | The Procter & Gamble Company | Compositions for delivery of oral comfort sensations |
CN106029175A (zh) | 2014-02-27 | 2016-10-12 | 宝洁公司 | 具有减少的苦味感受的口腔护理组合物 |
US20150272847A1 (en) | 2014-03-26 | 2015-10-01 | The Gillette Company | Skin Engaging Shaving Aid Comprising A Thermally Resilient Sensate And A TRPA1 Receptor Inhibitor |
US20150273711A1 (en) | 2014-03-26 | 2015-10-01 | The Gillette Company | Razor Comprising A Molded Shaving Aid Composition Comprising A Thermally Resilient Sensate |
CA2946383A1 (en) | 2014-04-23 | 2016-03-10 | The Procter & Gamble Company | Compositions for deposition on biological surfaces |
CA2956964C (en) | 2014-08-15 | 2019-07-16 | The Procter & Gamble Company | Oral care compositions with an enhanced sensory experience |
CA2955493A1 (en) | 2014-08-15 | 2016-02-18 | The Procter & Gamble Company | Oral care compositions and regimens |
CN111939090A (zh) | 2014-08-15 | 2020-11-17 | 宝洁公司 | 具有增量化学物质的牙粉 |
US10682778B2 (en) | 2014-11-26 | 2020-06-16 | The Gillette Company Llc | Skin engaging member comprising ethylene vinyl acetate |
US9951295B2 (en) | 2015-02-19 | 2018-04-24 | The Procter & Gamble Company | Compositions for deposition on biological surfaces |
EP3381453A3 (en) | 2015-04-09 | 2018-12-12 | The Procter & Gamble Company | Reduction in cpc taste aversion by reducing cpc activation of trpa1 receptors, tprv1 receptors, or both |
CN107920571A (zh) * | 2015-06-30 | 2018-04-17 | Wm.雷格利 Jr.公司 | 长效清凉制剂 |
US10035759B2 (en) | 2015-10-22 | 2018-07-31 | The Procter & Gamble Company | Method of chromatographic separation |
CN108349879A (zh) * | 2015-10-22 | 2018-07-31 | 宝洁公司 | 可在消费产品中用作感觉剂的环己烷甲酰胺衍生物的合成 |
MX2018007441A (es) | 2015-12-18 | 2018-11-09 | Procter & Gamble | Sintesis de derivados de ester de ciclohexano utiles como agentes de percepcion en productos de consumo. |
EP3435959A1 (en) | 2016-04-01 | 2019-02-06 | The Procter and Gamble Company | Oral care compositions containing a gel network phase |
WO2017173199A1 (en) | 2016-04-01 | 2017-10-05 | The Procter & Gamble Company | Oral care compositions with an effective flavor display |
CA3018598A1 (en) | 2016-04-01 | 2017-10-05 | The Procter & Gamble Company | Oral care compositions containing gel networks and potassium nitrate |
AU2017240683B2 (en) | 2016-04-01 | 2020-01-16 | The Procter & Gamble Company | Oral care compositions containing potassium nitrate and peroxide |
EP3435958A1 (en) | 2016-04-01 | 2019-02-06 | The Procter and Gamble Company | Oral care compositions containing a gel network phase and potassium nitrate |
US20170334082A1 (en) | 2016-05-18 | 2017-11-23 | The Gillette Company Llc | Skin Engaging Member Comprising Ethylene Vinyl Acetate |
CA3036897C (en) | 2016-10-25 | 2021-11-16 | The Procter & Gamble Company | Fibrous structures |
WO2018081192A1 (en) | 2016-10-25 | 2018-05-03 | The Procter & Gamble Company | Creped fibrous structures |
US20180117780A1 (en) | 2016-11-03 | 2018-05-03 | The Gillette Company Llc | Skin engaging member comprising ethylene vinyl acetate |
EP3541476A1 (en) | 2016-11-17 | 2019-09-25 | The Gillette Company LLC | Skin engaging member comprising ethylene vinyl acetate and a fragrance |
EP3577215A4 (en) * | 2017-02-03 | 2020-12-30 | The Johns Hopkins University | USE OF MINI-CANCERS FOR PERSONALIZED ANTI-CANCER DRUG PROTOCOLS |
CN112423729B (zh) | 2018-05-28 | 2023-07-11 | 宝洁公司 | 清凉感觉剂在口腔中的沉积功效改善的口腔护理组合物 |
KR102132713B1 (ko) | 2018-12-04 | 2020-07-13 | 주식회사 오스테온 | 모발 또는 두피 상태 개선용 조성물 |
GB201908219D0 (en) * | 2019-06-10 | 2019-07-24 | Axalbion Sa | Therapeutic use of a compound |
JP2023542022A (ja) | 2020-09-28 | 2023-10-04 | ザ プロクター アンド ギャンブル カンパニー | ホップ及び風味料を含む口腔ケア組成物 |
CA3219441A1 (en) | 2021-05-11 | 2022-11-17 | The Procter & Gamble Company | Oral care compositions comprising block copolymer |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4136163A (en) * | 1971-02-04 | 1979-01-23 | Wilkinson Sword Limited | P-menthane carboxamides having a physiological cooling effect |
US4150052A (en) * | 1971-02-04 | 1979-04-17 | Wilkinson Sword Limited | N-substituted paramenthane carboxamides |
GB1351761A (en) * | 1971-02-04 | 1974-05-01 | Wilkinson Sword Ltd | Substituted p-menthane carboxamides and compositions containing them |
US4178459A (en) * | 1971-02-04 | 1979-12-11 | Wilkinson Sword Limited | N-Substituted paramenthane carboxamides |
PH10359A (en) * | 1971-02-04 | 1977-01-05 | Wilkinson Sword Ltd | N-substituted-p-methane-3-carboxamides having physiological cooling activity and compositions containing them |
US3889804A (en) * | 1973-03-14 | 1975-06-17 | Gorham Int Inc | Disposable towel |
JP2978043B2 (ja) * | 1993-09-16 | 1999-11-15 | 高砂香料工業株式会社 | (2s)−3−{(1r,2s,5r)−[ 5−メチル−2−(1−メチルエチル)シクロヘキシル ]オキシ}−1,2−プロパンジオール,その製造方法および用途 |
US7189760B2 (en) * | 2004-04-02 | 2007-03-13 | Millennium Specialty Chemicals | Physiological cooling compositions containing highly purified ethyl ester of N-[[5-methyl-2-(1-methylethyl) cyclohexyl] carbonyl]glycine |
US20080227857A1 (en) * | 2005-03-29 | 2008-09-18 | Edward Tak Wei | N-Alkylcarbonyl-Amino Acid Ester and N-Alkylcarbonyl-Amino Lactone Compounds and Their Use |
-
2006
- 2006-03-23 CN CN2006800189445A patent/CN101184725B/zh active Active
- 2006-03-23 SI SI200630404T patent/SI1871738T1/sl unknown
- 2006-03-23 EP EP06710144A patent/EP1871738B1/en active Active
- 2006-03-23 WO PCT/GB2006/001093 patent/WO2006103401A2/en active Application Filing
- 2006-03-23 ZA ZA200709252A patent/ZA200709252B/xx unknown
- 2006-03-23 DK DK06710144T patent/DK1871738T3/da active
- 2006-03-23 DE DE602006007831T patent/DE602006007831D1/de active Active
- 2006-03-23 KR KR1020077024165A patent/KR20070116133A/ko not_active Application Discontinuation
- 2006-03-23 PL PL06710144T patent/PL1871738T3/pl unknown
- 2006-03-23 PT PT06710144T patent/PT1871738E/pt unknown
- 2006-03-23 MX MX2007011831A patent/MX2007011831A/es active IP Right Grant
- 2006-03-23 BR BRPI0609784A patent/BRPI0609784C1/pt active IP Right Grant
- 2006-03-23 AU AU2006228280A patent/AU2006228280B2/en active Active
- 2006-03-23 ES ES06710144T patent/ES2328847T3/es active Active
- 2006-03-23 CA CA2602075A patent/CA2602075C/en active Active
- 2006-03-23 JP JP2008503573A patent/JP2008538115A/ja active Pending
- 2006-03-23 EP EP09165292A patent/EP2161252A1/en not_active Withdrawn
-
2007
- 2007-09-25 IL IL186297A patent/IL186297A0/en unknown
-
2008
- 2008-01-15 HK HK08100492.5A patent/HK1106761A1/xx unknown
-
2009
- 2009-09-23 CY CY20091100988T patent/CY1109420T1/el unknown
-
2010
- 2010-10-29 JP JP2010243617A patent/JP2011068656A/ja active Pending
- 2010-12-06 US US12/928,184 patent/US20110082204A1/en not_active Abandoned
-
2011
- 2011-01-18 US US12/930,794 patent/US8853267B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2161252A1 (en) | 2010-03-10 |
JP2011068656A (ja) | 2011-04-07 |
CA2602075C (en) | 2014-04-29 |
DE602006007831D1 (de) | 2009-08-27 |
BRPI0609784B8 (pt) | 2020-07-21 |
PT1871738E (pt) | 2009-09-11 |
ES2328847T3 (es) | 2009-11-18 |
IL186297A0 (en) | 2008-01-20 |
BRPI0609784A8 (pt) | 2017-07-11 |
WO2006103401A2 (en) | 2006-10-05 |
US20110082204A1 (en) | 2011-04-07 |
BRPI0609784A2 (pt) | 2010-04-27 |
CA2602075A1 (en) | 2006-10-05 |
US20110152366A1 (en) | 2011-06-23 |
WO2006103401A3 (en) | 2007-03-08 |
JP2008538115A (ja) | 2008-10-09 |
BRPI0609784B1 (pt) | 2020-07-07 |
PL1871738T3 (pl) | 2009-12-31 |
EP1871738A2 (en) | 2008-01-02 |
EP1871738B1 (en) | 2009-07-15 |
SI1871738T1 (sl) | 2009-12-31 |
BRPI0609784C1 (pt) | 2021-05-25 |
KR20070116133A (ko) | 2007-12-06 |
ZA200709252B (en) | 2009-04-29 |
MX2007011831A (es) | 2007-11-21 |
AU2006228280B2 (en) | 2012-08-30 |
HK1106761A1 (en) | 2008-03-20 |
CN101184725B (zh) | 2012-03-21 |
CN101184725A (zh) | 2008-05-21 |
AU2006228280A1 (en) | 2006-10-05 |
US8853267B2 (en) | 2014-10-07 |
CY1109420T1 (el) | 2014-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1871738T3 (da) | N-alkylcarbonylaminosyreester- og N-alkylcarbonylaminolactonforbindelser og deres anvendelse | |
NO20085030L (no) | Pyrrolopyrimidinforbindelser og deres anvendelser | |
DK1954140T3 (da) | Glycerollevulinatketaler og deres anvendelse | |
DE602006018478D1 (de) | Ür | |
CY2014030I1 (el) | Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate | |
DK2023902T3 (da) | DPP-IV-inhibitor-formuleringer | |
DK1940839T3 (da) | Pyridopyrimidione Inhibitors of P13Ka | |
DK1888595T3 (da) | Spiro-oxindolforbindelser og deres anvendelser som terapeutiske midler | |
DK2079485T3 (da) | Phenylpropionamidforbindelser og anvendelsen deraf | |
DE602005008726D1 (de) | Verwendet | |
DK3524657T3 (da) | Sammensætninger omfattende hfc-1234yf og hfc-32 | |
DE602006012066D1 (de) | Daraus | |
DK1937276T3 (da) | Forbedret testosterongel og fremgangsmåde til anvendelse deraf | |
DK2001556T3 (da) | Thioninium-forbindelser og anvendelse deraf | |
DK2158199T3 (da) | Piperidinforbindelser og anvendelser deraf | |
DK1885716T3 (da) | Thiazolderivater og anvendelse deraf | |
FR2881947B1 (fr) | Orthese reversible | |
ATE488493T1 (de) | Biphenyl- und naphthylphenylhydroxamsäurederivate | |
DK1958948T3 (da) | Pyridazinforbindelse og anvendelse deraf | |
DE502006009120D1 (de) | Ür | |
ATE478853T1 (de) | Thiazolcarbonsäureanilide | |
FR2882621B1 (fr) | Andaineuse reversible | |
ATE420094T1 (de) | Substituierte propanphosphinsäureester | |
FI20051349A0 (fi) | Uima-allas | |
ES1060691Y (es) | Ataud |